Moody’s downgrades Senegal to Caa1 amid rising debt concerns
Investing.com -- GoodRx Holdings (NASDAQ:GDRX) stock surged 18% after reports emerged that the prescription drug savings platform is in discussions with the Trump administration about participating in the upcoming TrumpRx website initiative.
The company is among several retail pharmacies engaging with the administration about potential involvement in TrumpRx, according to Reuters. This suggests the platform may expand beyond its initially described purpose of connecting consumers to pharmaceutical companies’ direct discount programs.
TrumpRx, scheduled to launch next year, aims to provide consumers access to medications at discounted prices. The initiative was announced at a recent White House event, where President Donald Trump and health officials presented it as a way for Americans to obtain drugs at lower costs.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.